Home
Ingeborg M. Bachmann's picture

Ingeborg M. Bachmann

Professor
  • E-mailIngeborg.Bachmann@uib.no
  • Phone+47 55 97 31 60
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
  • Postal Address
    Postboks 7804
    5020 Bergen
Journal articles
  • Hugdahl, Emilia Signe; Bachmann, Ingeborg M.; Schuster, Cornelia; Ladstein, Rita Grude; Akslen, Lars A. 2019. Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma. PLoS ONE. 14:e0210399: 1-18. doi: 10.1371/journal.pone.0210399
  • Iversen, Lars F.; Eidsmo, Liv; Austad, Joar; de Rie, Menno A.; Osmancevic, Amra; Skov, Lone; Talme, Toomas; Bachmann, Ingeborg M.; van de Kerkhof, Peter C.M.; Ståhle, Mona; Banerjee, Rudrani; Oliver, Jaime; Fasth, Anna; Frueh, Jennifer. 2018. Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study. Journal of the European Academy of Dermatology and Venereology. 32: 1930-1939. doi: 10.1111/jdv.14979
  • Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn; Akslen, Lars A. 2014. Nestin expression is associated with aggressive cutaneous melanoma of the nodular type. Modern Pathology. 27: 396-401. doi: 10.1038/modpathol.2013.151
  • Geisler, Jürgen; Bachmann, Ingeborg M.; Nyakas, Marta Sølvi; Helsing, Per; Fjøsne, Hans E.; Mæhle, Lovise Olaug; Aamdal, Steinar; Eide, Nils; Svendsen, Henrik Løvendahl; Straume, Oddbjørn; Robsahm, Trude Eid; Dolven-Jacobsen, Kari; Akslen, Lars A. 2013. Malignt melanom – diagnostikk, behandling og oppfølging i Norge. Tidsskrift for Den norske legeforening. 133: 2154-2159. doi: 10.4045/tidsskr.12.1416
  • Puntervoll, Hanne Eknes; Yang, Xiaohong R.; Vetti, Hildegunn Høberg; Bachmann, Ingeborg M.; Avril, Marie Françoise; Benfodda, Meriem; Catricala, Caterina; Dalle, Stéphane; Duval-Modeste, Anne B.; Ghiorzo, Paola; Grammatico, Paola; Harland, Mark; Hayward, Nicholas K.; Hu, Hui-Han; Jouary, Thomas; Martin-Denavit, Tanguy; Ozola, Aija; Palmer, Jane M.; Pastorino, Lorenza; Pjanova, Dace; Soufir, Nadem; Steine, Solrun; Stratigos, Alexander J.; Thomas, Luc; Tinat, Julie; Tsao, Hensin; Veinalde, Rūta; Tucker, Margaret A.; Bressac-de Paillerets, Brigitte B.D.; Newton-Bishop, Julia A.; Goldstein, Alisa M.; Akslen, Lars A.; Molven, Anders. 2013. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. Journal of Medical Genetics. 50: 264-U82. doi: 10.1136/jmedgenet-2012-101455
  • Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn; Akslen, Lars A. 2012. Tumor necrosis is a prognostic factor in thick cutaneous melanoma. American Journal of Surgical Pathology. 36: 1477-1482. doi: 10.1097/PAS.0b013e31825a5b45
  • Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn; Akslen, Lars A. 2012. Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma. Journal of Investigative Dermatology. 132: 1247-1252. doi: 10.1038/jid.2011.464
  • Straume, Oddbjørn; Shimamura, Takeshi; Lampa, Michael J.G.; Carretero, Julian; Øyan, Anne Margrete; Jia, Di; Borgman, Christa L.; Soucheray, Margaret; Downing, Sean R.; Short, Sarah M.; Kang, Soo-Young; Wang, Suoming; Chen, Liang; Collett, Karin; Bachmann, Ingeborg M.; Wong, Kwok-Kin; Shapiro, Geoffrey I.; Kalland, Karl-Henning; Folkman, Judah; Watnick, Randolph S.; Akslen, Lars A.; Naumov, George N. 2012. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: 8699-8704. doi: 10.1073/pnas.1017909109
  • Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn; Akslen, Lars A. 2010. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma. BMC Cancer. 10. 15 pages. doi: 10.1186/1471-2407-10-140
  • Akslen, Lars A.; Puntervoll, Hanne Eknes; Bachmann, Ingeborg M.; Straume, Oddbjørn; Vuhahula, Edda; Kumar, Rajiv; Molven, Anders. 2008. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. Melanoma research. 18: 29-35.
  • Bachmann, Ingeborg M.; Ladstein, Rita Grude; Straume, Oddbjørn; Naumov, GN; Akslen, Lars A. 2008. Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. BMC Cancer. 8: 362-372. doi: 10.1186/1471-2407-8-362
  • Bachmann, Ingeborg M.; Puntervoll, Hanne Eknes; Otte, Arie P.; Akslen, Lars A. 2008. Loss of BMI-1 expression is associated with clinical progress of malignant melanoma. Modern Pathology. 21: 583-590. doi: 10.1038/modpathol.2008.17
  • Bachmann, Ingeborg M.; Eknes, HE; Otte, Ariel P.; Akslen, Lars A. 2007. Loss of BMI-1 expression is associated with the clinical progress of malignant melanoma. Virchows Archiv. 451: 452-452.
  • Bachmann, Ingeborg Margrethe; Halvorsen, Ole Johan; Collett, Karin; Stefansson, Ingunn Marie; Straume, Oddbjørn; Haukaas, Svein Andreas; Salvesen, Helga; Otte, Arie P.; Akslen, Lars A. 2006. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. Journal of Clinical Oncology. 24: 268-273. doi: 10.1200/JCO.2005.01.5180
  • Akslen, Lars A.; Angelini, Sabrina; Straume, Oddbjørn; Molven, Anders; Bachmann, Ingeborg; Hemminki, Kari; Kumar, Rajiv. 2005. BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. Journal of Investigative Dermatology. 125: 312-317.
  • Bachmann, Ingeborg; Straume, Oddbjørn; Puntervoll, Hanne Eknes; Kalvenes, May Britt; Akslen, Lars A. 2005. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clinical Cancer Research. 11: 8606-8614. doi: 10.1158/1078-0432.CCR-05-0011
  • Bachmann, Ingeborg; Straume, Oddbjørn; Akslen, Lars A. 2004. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas. International Journal of Oncology. 25: 1559-1565.
Reports and theses
  • Bachmann, Ingeborg M. 2007. Biological Markers in Cutaneous Melanoma. A study with special focus on cell cycle regulation, cell adhesion proteins and tumor necrosis.

More information in national current research information system (CRIStin)